Ridgefield, Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. was not upfront about the risks of its blood thinner, Pradaxa, a federal jury found Wednesday evening before returning a $1.25 million award for the family of an 84-year-old woman who died of severe bleeding.

The nine-person jury in the Southern District of West Virginia, Huntington Division, found for the family of Betty Knight on the count of fraud, awarding $50,000 in medical expenses and $200,000 in pain and suffering. It also awarded the family $1 million in punitive damages. But jurors found for the company, which is headquartered in Germany, on the first four counts regarding adequacy of warning labels and warrant claims.